For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of Tafamidis and Tafamidis meglumine represents a true advancement . These innovative therapies stabilize the transthyretin protein, halting its damaging build-up and alleviating the burden of the disease . Individuals are now experien